Emyria Unlocks Treatment Capacity
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Emyria Ltd has announced the resolution of capacity constraints for Authorised Prescribers, enabling increased treatment capacity in Perth and Queensland operations. This expansion aims to enhance treatment volumes and improve the utilization of existing clinical infrastructure, providing a pathway to revenue growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Emyria
- June 2026 Quarterly Activities Report and Appendix 4C
- Emyria Depression Program Shows Positive Results
- Emyria Confirms NSW Workforce Ahead of Clinic Opening
- Emyria Company Update Presentation
- TGA Update to Accelerate Empax Therapist Recruitment
Later from Emyria
- Appendix 4E & Annual Financial Report Year End 30 June 2026
- Emyria Set to Launch First NSW Clinic
- FDA Selects EMD to Present at Psychedelic Medicines Hearing
- Emyria Successfully Opens First NSW Empax Clinic
- September 2026 Quarterly Activities Report and Appendix 4C
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria